CHARACTERISTICS OF THE MANAGEMENT OF A COMORBID PATIENT. LOOKING AT THE PROBLEM FROM THE EYES OF A FAMILY DOCTOR

  • Вовк К.В. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
  • Власенко О.О. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
  • Шерстюк Л.Л. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
  • Шумова Н.В. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
  • Кратенко Г.С. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
  • Резніченко О.Г. к. мед. н., Україна, м. Харків, Харківський національний університет імені В. Н. Каразіна, медичний факультет
Keywords: Comorbid Patients, Effectiveness of the Treatment, Cardiovascular and Digestive Systems

Abstract

In the realities of today, family doctors are increasingly faced with comorbid patients. Moreover, with an increase in the life expectancy of people, this problem becomes large and infinitely diverse. Comorbidity can reduce patient adherence to treatment, including due to the use of multicomponent therapy regimens, which, in turn, leads to a decrease in the effectiveness of the treatment. In this regard, there is a need for individual selection of therapeutic regimens with minimal drug interactions. This imposes certain conditions on the family doctor in terms of continuous improvement in the study of the latest protocols and treatment regimens of all therapeutic specialties. This article presents a clinical case of a comorbid patient with pathology of the cardiovascular and digestive systems. The choice of a diagnostic and treatment algorithm was based on modern Ukrainian and foreign recommendations. Emphasis is placed on the stratification of both cardiac and gastroenterological risk factors, and the strategy for choosing proton pump inhibitors depending on the clinical dynamics. On a specific clinical example, an algorithm for choosing the diagnosis and treatment of a comorbid patient under different scenarios of pathology development, taking into account existing approaches and recommendations, is demonstrated. It has been shown that the problem of comorbidity leaves many questions for practitioners and often requires broad knowledge from the attending physician, and sometimes a multidisciplinary approach.

References

Patrono C., Baigent C., Hirsh J., Roth G. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2018; 133:199-233.

Lanas A. Cyclo-oxygenase-1/cyclo-oxygenase-2 non selective non-steroidal anti-inflammatory drugs: epidemiology of gastrointestinal events. Dig Liver Dis. 2021; 2:29-34.

Burmester G, Lanas A, Biasucci L, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2017;70(5):818-22. doi: 10.1136/ard.2010.128660.

Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterology. 2016;101(4);701-10. doi: 10.1111/j.1572-0241.2006

Blume H., Donath F., Warnke A., Schug B. S. Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors. Drug Safety. 2020;29(9):769-84.

Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection the Maastricht IV. Florence Consensus Report. Gut. 2012; 61:646-64. doi: 10.1136/gutjnl-2012- 302084.

Chan FK, Abraham NS, Scheiman JM, et al. Management of patients on nonsteroidal anti-inflamma- tory drugs: a clinical practice recommendation from the First International Working Party on Gastroin- testinaland Cardiovascular Effects of Nonsteroidal Anti-inflammatory. Drugs and Anti-platelet Agents. Am J Gastroenterol. 2008;103(11):2908-18. doi: 10.1111/j.1572-0241.2008

Lanza F.L., Chan F.K., Quigley E.M. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728-38. doi: 10.1038/ajg.2009.115.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group.. Cana- dian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009;481-96. doi: 10.1111/j.1365- 2036.2008

Yeomans N, Lanas A, Labenz J, et. al. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroen- terology. 2008;103(10):2465-73. doi: 10.1111/j.1572-0241.2008

Bhatt D.L., Fox K.A., Hacke W. et al. CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706-17. doi: 10.1056/NEJMoa060989.

Juurlink D.N., Gomes T, Ko D.T. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7): 713-8. doi: 10.1503/cmaj.082001.

Li X. Q., Andersson T. B., Ahlstrom M. et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004; 32:821-7. Doi: 10.1124/dmd.32.8.821.

Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002.

Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Com- mittee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366- 74.doi:10.1016/S0735-1097(02)02336-7.

Views:

66

Downloads:

42

Published
2023-09-22
Citations
How to Cite
Вовк К.В., Власенко О.О., Шерстюк Л.Л., Шумова Н.В., Кратенко Г.С., & Резніченко О.Г. (2023). CHARACTERISTICS OF THE MANAGEMENT OF A COMORBID PATIENT. LOOKING AT THE PROBLEM FROM THE EYES OF A FAMILY DOCTOR. World Science, (3(81). https://doi.org/10.31435/rsglobal_ws/30092023/8036
Section
Medicine